间充质干细胞移植干预盆腔脏器脱垂的现状和研究进展  

Current status and research progress of mesenchymal stem cell transplantation in pelvic organ prolapse

作　　者：彭沙[1] PENG Sha(Department of Gynecology,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing Maternal and Child Health Care Hospital,Beijing 100026,China)

机构地区：[1]首都医科大学附属北京妇产医院北京妇幼保健院妇科,北京100026

出　　处：《妇儿健康导刊》2023年第8期32-35,42,F0004,共6页JOURNAL OF WOMEN AND CHILDREN'S HEALTH GUIDE

摘　　要：盆腔脏器脱垂是妇科常见病,严重影响患者的生活质量。目前以手术修复和网片植入为主要治疗手段,然而术后严重的并发症导致该病复发率居高不下。近年来,间充质干细胞在损伤修复和退行性病变的干预中显现出极大的应用前景。本文综述间充质干细胞在盆腔脏器脱垂中的研究进展,旨在为该病的临床干预提供新的治疗思路和理论基础。Pelvic organ prolapse(POP)is a common gynecological disease and severely affects the quality of life of patients.Surgical repair and mesh implantation are the main interventions to POP in clinic.However,serious postoperative complications lead to a high recurrence rate.In recent years,mesenchymal stem cells have shown great promise in the intervention of injury repair and degenerative lesions.This article reviews the research progress of mesenchymal stem cells in POP,aiming to provide new therapeutic ideas and theoretical basis for the clinical intervention of this disease.

关 键 词：盆腔脏器脱垂 间充质干细胞 细胞移植 

分 类 号：R713[医药卫生—妇产科学]